Clearmind Medicine Inc. Interest Expense
Clearmind Medicine Inc. (CMND) reported Interest Expense of $3.86 thousand for the 12-month period ending 2025-10-31, per its 20-F filed 2026-01-20.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2026-01-20
CAD
| Period end | Interest Expense 12 month |
|---|---|
| 2022-10-31 | 19.68K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Interest Expense 12 month |
|---|---|
| 2025-10-31 | $3.86K 20-F · filed 2026-01-20 |
| 2024-10-31 | $5.39K 20-F · filed 2026-01-20 |